Difference between revisions of "Brio™ Rechargeable IPG"
Jump to navigation
Jump to search
(image) |
(infobox) |
||
| Line 21: | Line 21: | ||
weight=29| | weight=29| | ||
weight_commentary=<ref name="Newswise">St. Jude Medical. St. Jude Medical Receives CE Mark Approval for World’s Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson’s Disease. Newswise, Inc [online]. 2009, Sep 9. Available online at: http://www.newswise.com/articles/st-jude-medical-receives-ce-mark-approval-for-world-s-smallest-longest-lasting-rechargeable-deep-brain-stimulator-for-parkinson-s-disease-first-patient-implanted-with-brio-neurostimulator-at-university-of-cologne-germany32(Retrieved 6th April, 2017).</ref>| | weight_commentary=<ref name="Newswise">St. Jude Medical. St. Jude Medical Receives CE Mark Approval for World’s Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson’s Disease. Newswise, Inc [online]. 2009, Sep 9. Available online at: http://www.newswise.com/articles/st-jude-medical-receives-ce-mark-approval-for-world-s-smallest-longest-lasting-rechargeable-deep-brain-stimulator-for-parkinson-s-disease-first-patient-implanted-with-brio-neurostimulator-at-university-of-cologne-germany32(Retrieved 6th April, 2017).</ref>| | ||
| − | controls1= | + | controls1=Brio™ Patient Programmer| |
| − | + | controls_commentary=<ref>St. Jude Medical. Brio™ Patient Programmer. U.S. Food and Drug Administration [online]. Available online at: www.accessdata.fda.gov/cdrh_docs/pdf14/P140009c.pdf (Retrieved 6th April, 2017).</ref>| | |
| − | |||
| − | controls_commentary=| | ||
data_available=| | data_available=| | ||
risk_factor=| | risk_factor=| | ||
Revision as of 10:54, 6 April 2017
| Brio™ Rechargeable IPG | |
|---|---|
|
|
| Category | Deep brain stimulation |
| Developer | St. Jude Medical [1] |
| Announced | 2009 [1] |
| Released | Developers:
Consumers: 2009 [1] |
| Price | 19,150 USD [2] |
| Max output | 12.512.5 T 12.5 mA 0.0125 A [3] |
| Session duration | 0.050.05 s 8.333334e-4 minute [4] |
| Scalp location | subthalamic nucleus, globus pallidus internus [5][6] |
| Weight | 29 g [1] |
| Controls |
Brio™ Patient Programmer [7] |
| Data available | |
| Risk factor | |
| Medical prescription | |
| https://www.sjmglobal.com/en-int/professionals/featured-products/neuromodulation/deep-brain-stimulation/implantable-pulse-generators/brio-ipg | |
http://www.medicalnewstoday.com/articles/295376.php?trendmd-shared=0
http://www.businesswire.com/news/home/20090909005095/en/St.-Jude-Medical-Receives-CE-Mark-Approval
Contents
Main characteristics
Purpose
Company & People
Important Dates
Enhancement/Therapy/Treatment
Ethical & Health Issues
http://onlinelibrary.wiley.com/doi/10.1111/ner.12026/full
Public & Media Impact and Presentation
Public Policy
Related Technologies, Projects or Scientific Research
References
- ↑ 1.0 1.1 1.2 1.3 St. Jude Medical. St. Jude Medical Receives CE Mark Approval for World’s Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson’s Disease. Newswise, Inc [online]. 2009, Sep 9. Available online at: http://www.newswise.com/articles/st-jude-medical-receives-ce-mark-approval-for-world-s-smallest-longest-lasting-rechargeable-deep-brain-stimulator-for-parkinson-s-disease-first-patient-implanted-with-brio-neurostimulator-at-university-of-cologne-germany32(Retrieved 6th April, 2017).
- ↑ Australian Government. Private Health Insurance (Prostheses) Rules 2015 (No. 1). Federal Register of Legislation [online]. Available online at: https://www.legislation.gov.au/Details/F2015C00649/Html/Volume_2 (Retrieved 6th April, 2017).
- ↑ TODO
- ↑ TODO
- ↑ OKUN, M. et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. The Lancet Neurology, 2012, 11(2), 140-149. Available online at: http://www.sciencedirect.com/science/article/pii/S1474442211703088 (Retrieved 6th April, 2017).
- ↑ PREDA, F. et al. Switching from constant voltage to constant current in deep brain stimulation: a multicenter experience of mixed implants for movement disorders. European Journal of Neurology, 2016, 23(1), 190–195. Doi:10.1111/ene.12835 Available online at: http://onlinelibrary.wiley.com/doi/10.1111/ene.12835/full (Retrieved 6th April, 2017).
- ↑ St. Jude Medical. Brio™ Patient Programmer. U.S. Food and Drug Administration [online]. Available online at: www.accessdata.fda.gov/cdrh_docs/pdf14/P140009c.pdf (Retrieved 6th April, 2017).
